Furthermore, data mining of publicly available datasets from three independent clinical cohorts25–27, consistently confirmed lower GCNT2 mRNA levels in clinical melanoma specimens compared to normal melanocytes (Fig. 2f). This evidence concerns the gene GCNT2 and melanoma.